Adeyinka Abimbola Adegoroye, MBCHB

Adeyinka Adegoroye practices at High Point Surgical Oncology - Surgical Oncology Services - Westwood - HOPD in High Point, North Carolina.

Adeyinka Adegoroye's NPI, 1952500423, was assigned on July 16, 2007. Adeyinka Adegoroye holds North Carolina license 2010-00955.

Adeyinka Adegoroye's primary practice is High Point Surgical Oncology - Surgical Oncology Services - Westwood - HOPD, at 404 Westwood Ave, High Point, NC 27262.

Adeyinka Adegoroye's primary practice is High Point Surgical Oncology - Surgical Oncology Services - Westwood - HOPD in High Point, North Carolina. Adeyinka Adegoroye is also affiliated with High Point Medical Center. The medical group on file is High Point Nephrology Associates. Dmand AI also links Adeyinka Adegoroye to 1 more hospital, 1 dialysis center and 1 group practice or clinic, each named with a free account. Adeyinka Adegoroye's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Adeyinka Adegoroye practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Adeyinka Adegoroye's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Adeyinka Adegoroye's licenses on file in 2 states: North Carolina and New York.

CMS data shows 703 Medicare services from Adeyinka Adegoroye across 7 procedure codes in 2024, for 164 Medicare patients. Medicare paid $60,926 for them.

CMS counts 164 Medicare patients who saw Adeyinka Adegoroye in 2024. The largest group is 75 to 84, with 73 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 4.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Adeyinka Adegoroye's median patient age at 71, with 51% women.

In 2024, Adeyinka Adegoroye wrote 1,881 Medicare Part D claims for 273 patients. 90% of them were for generic drugs. CMS names the drug for 1,589 of them, across 45 drugs with 11 or more claims each, at $77,369 in total drug cost. In 2023, CMS named 1,576 claims across 45 drugs.

Adeyinka Adegoroye accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 59 general payments to Adeyinka Adegoroye from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Mallinckrodt LLC paid the most, $233.